RecallDepth
Class III Terminated

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

Company
Stason Pharmaceuticals, Inc.
Recall Initiated
February 9, 2024
Posted
March 13, 2024
Recall Number
D-0367-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
54, 131 bottles
Firm Location
Irvine, CA, United States

Reason for Recall

Failed Dissolution Specifications: results slightly under spec at at 9-months.

Distribution

USA Nationwide

Lot / Code Info

Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024.

More recalls by Stason Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls